iCAD
About
iCAD, Inc. is a global medical technology company specializing in AI-powered solutions for cancer detection and therapy. Their ProFound Breast Health Suite offers clinically validated tools for early cancer detection, automated breast density assessment, and personalized short-term risk evaluation, aiming to improve patient outcomes.
Key facts
At-a-glance profile data
- Website
- icadmed.com
- Headquarters
- Nashua, United States
- Founded
- 1984
- Employees
- 353
- Total funding
- $113M (Direct Offering)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Apr 2020 | Direct Offering | $13M | - |
| 1 Jan 2005 | Series D | $50M | - |
| 1 Jan 2003 | Series C | $25M | - |
| 1 Jan 2001 | Series B | $15M | - |
| 1 Jan 2000 | Series A | $10M | - |
Tech stack
Detected on icadmed.com, last scanned 26 Sept 2026. Run your own scan
- SEO
- Yoast SEO
- CMS / Builders
- Ghost
- CDN
- Cloudflare
- Email provider
- Mimecast
- Email marketing
- Adobe Marketo
Add first review
Frequently asked
How much funding has iCAD raised?
iCAD has raised a total of $113M in funding. The most recent round on record is Direct Offering.
How many employees does iCAD have?
iCAD has approximately 353 people on record.